Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s00296-020-04744-9 http://scihub22266oqcxt.onion/10.1007/s00296-020-04744-9 33205224!7671668!33205224     free     free     free       Rheumatol+Int 2021 ; 41 (1): 1-5 Nephropedia Template TP {{tp|p=33205224|t=2021. COVID-19 pandemic in Japan |pdf=|usr=}}{{33205224}} gab.com Text COVID-19 pandemic in Japan JO: Rheumatol Int http://www.kidney.de/pget.php?&tw=1&pmid=33205224 #FOAvip The disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Coronavirus Disease-2019 (COVID-19), is a global emergency. The first case of COVID-19 was confirmed in Japan in January 2020, a second outbreak of infection occurred in mid-March and a third peak at the beginning of August. The COVID-19 phenotype was milder in Japan than in other countries, although the restrictive measures applied in the country have not been as strict as in other places. Factors related to a possible reduced susceptibility to the pulmonary manifestations of SARS-CoV-2 may have contributed to better outcomes and lower mortality in Japan. Twit Text FOAVip COVID-19 pandemic in Japan ????Rheumatol Int http://www.kidney.de/pget.php?&tw=1&pmid=33205224 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33205224 #FOAvip English Wikipedia <ref>{{Cite pmid|33205224}}</ref> COVID-19 pandemic in Japan #MMPMID33205224 Amengual O; Atsumi T Rheumatol Int 2021[Jan]; 41 (1): 1-5 PMID33205224show ga The disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Coronavirus Disease-2019 (COVID-19), is a global emergency. The first case of COVID-19 was confirmed in Japan in January 2020, a second outbreak of infection occurred in mid-March and a third peak at the beginning of August. The COVID-19 phenotype was milder in Japan than in other countries, although the restrictive measures applied in the country have not been as strict as in other places. Factors related to a possible reduced susceptibility to the pulmonary manifestations of SARS-CoV-2 may have contributed to better outcomes and lower mortality in Japan. |COVID-19/*mortality[MESH] |Comorbidity[MESH] |Humans[MESH] |Japan/epidemiology[MESH] |Pandemics/prevention & control[MESH] |Rheumatic Diseases/complications[MESH]COVID-19 pandemic in Japan (epmc).pdf DeepDyve Pubget Overpricing